{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T18:59:31Z","timestamp":1783623571157,"version":"3.55.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":266,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Peptihub (https:\/\/bioinformaticscollege.ir\/peptihub\/) is a meticulously curated repository of cancer-related peptides (CRPs) that have been documented in scientific literature. A diverse collection of CRPs is included in the PeptiHub, showcasing a spectrum of effects and activities. While some peptides demonstrated significant anticancer efficacy, others exhibited no discernible impact, and some even possessed alternative non-drug functionalities, including drug carrier or carcinogenic attributes. Presently, Peptihub houses 874 CRPs, subjected to evaluation across 10 distinct organism categories, 26 organs, and 438 cell lines. Each entry in the database is accompanied by easily accessible 3D conformations, obtained either experimentally or through predictive methodology. Users are provided with three search frameworks offering basic, advanced, and BLAST sequence search options. Furthermore, precise annotations of peptides enable users to explore CRPs based on their specific activities (anticancer, no effect, insignificant effect, carcinogen, and others) and their effectiveness (rate and IC50) under cancer conditions, specifically within individual organs. This unique property facilitates the construction of robust training and testing datasets. Additionally, PeptiHub offers 1141 features with the convenience of selecting the most pertinent features to address their specific research questions. Features include aaindex1 (in six main subcategories: alpha propensities, beta propensity, composition indices, hydrophobicity, physicochemical properties, and other properties), amino acid composition (Amino acid Composition and Dipeptide Composition), and Grouped Amino Acid Composition (Grouped amino acid composition, Grouped dipeptide composition, and Conjoint triad) categories. These utilities not only speed up machine learning-based peptide design but also facilitate peptide classification.<\/jats:p>\n               <jats:p>Database URL: https:\/\/bioinformaticscollege.ir\/peptihub\/<\/jats:p>","DOI":"10.1093\/database\/baae092","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T06:08:16Z","timestamp":1727071696000},"source":"Crossref","is-referenced-by-count":18,"title":["PeptiHub: a curated repository of precisely annotated cancer-related peptides with advanced utilities for peptide exploration and discovery"],"prefix":"10.1093","volume":"2024","author":[{"given":"Sara","family":"Zareei","sequence":"first","affiliation":[{"name":"Department of Cell & Molecular Biology, Faculty of Biological Sciences, Kharazmi University , South Mofateh Ave. , Tehran 15719-14911, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1585-3909","authenticated-orcid":false,"given":"Babak","family":"Khorsand","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California , 200 S. Manchester Ave., Suite 206 Orange, Irvine, CA 92868-4280, USA"},{"name":"Department of Computer Engineering, Faculty of Engineering, Ferdowsi University of Mashhad , Azadi Square , Mashhad 9177948974, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Dantism","sequence":"additional","affiliation":[{"name":"Department of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University , Jalal AlAhmad HWY, Tehran 14115-111, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Zareei","sequence":"additional","affiliation":[{"name":"Transplant Research Center, Shiraz University of Medical Sciences , Khalili Str, Shiraz 7193711351, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Asgharzadeh","sequence":"additional","affiliation":[{"name":"Department of Medical Physiology, Faculty of Medicine, Mashhad University of Medical Sciences , Azadi Sq., Mashhad 9177948564, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi Shams","family":"Zahraee","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences and Biotechnology, Shahid Beheshti University , Dr. Shahriari Sq., Tehran 1983969411, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samane","family":"Mashreghi Kashan","sequence":"additional","affiliation":[{"name":"Department of Medicinal Biotechnology, Faculty of Advanced Technology in Medicine, Golestan University of Medical Sciences , Shast Kola Road, Gorgan 4918936316, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Hekmatirad","sequence":"additional","affiliation":[{"name":"Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences , 16 Azar Ave, Tehran 1416753955, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shila","family":"Amini","sequence":"additional","affiliation":[{"name":"Department of Genetics, Faculty of Advanced Science and Technology, Medical Sciences Branch, Islamic Azad University , Shariati St., Tehran 19395\/1495, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghasemi","sequence":"additional","affiliation":[{"name":"Department of Computer Engineering, Faculty of Engineering, Ferdowsi University of Mashhad , Azadi Square , Mashhad 9177948974, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Moradnia","sequence":"additional","affiliation":[{"name":"Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Faculty of Medicine, Lund University , Lund BOX 117,221 00, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atena","family":"Vaghf","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Faculty of Advanced Technologies, Shahrekord University of Medical Science , Kashani BLVD., Shahrekord 8815713471, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahid","family":"Hemmatpour","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences and Health Services , Aalam Sq., Yazd 8915173149, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdam","family":"Hourfar","sequence":"additional","affiliation":[{"name":"Bioprocess Engineering Research Group, Department of Industrial and Environmental Biotechnology, National Institute for Genetic Engineering and Biotechnology , Tehran-Karaj HWY, Tehran 14965\/161, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudabeh","family":"Niknia","sequence":"additional","affiliation":[{"name":"Department of Biology, Kavian Institute of Higher Education , Elahiyeh Blv., Mashhad 91863-74915, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Johari","sequence":"additional","affiliation":[{"name":"Department of Biology, Kavian Institute of Higher Education , Elahiyeh Blv., Mashhad 91863-74915, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Salimi","sequence":"additional","affiliation":[{"name":"Department of Clinical Science, Faculty of Veterinary Medicine, Razi University , Taq-e Bostan, Kermanshah 6714414971, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Fariborzi","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, Faculty of Molecular Biology and Genetics, University of Pavia , S.da Nuova, Pavia 65, 27100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Shojaei","sequence":"additional","affiliation":[{"name":"Department of Cell & Molecular Biology, Faculty of Biological Sciences, Kharazmi University , South Mofateh Ave. , Tehran 15719-14911, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Asiaei","sequence":"additional","affiliation":[{"name":"Systems Biotechnology Research Group, Department of Industrial and Environmental Biotechnology, National Institute for Genetic Engineering and Biotechnology , Tehran-Karaj HWY., Tehran 14965\/161, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Shabani","sequence":"additional","affiliation":[{"name":"Department of Biology, Faculty of Biosciences, Tehran North Branch, Islamic Azad University , Vafadar Blv., Tehran 1651153311, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"2024092306074217200_R1","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00332-w","article-title":"Anti-cancer peptide-based therapeutic strategies in solid tumors","volume":"27","author":"Karami Fath","year":"2022","journal-title":"Cell Mol Biol Lett"},{"key":"2024092306074217200_R2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00121","article-title":"Neoantigens in hematologic malignancies","volume":"11","author":"Biernacki","year":"2020","journal-title":"Front Immunol"},{"key":"2024092306074217200_R3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00245","article-title":"Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?","volume":"9","author":"Nurgali","year":"2018","journal-title":"Front. Pharmacol."},{"key":"2024092306074217200_R4","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.2174\/092986712801661004","article-title":"The use of therapeutic peptides to target and to kill cancer cells","volume":"19","author":"Boohaker","year":"2012","journal-title":"Curr Med Chem"},{"key":"2024092306074217200_R5","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-03911-3","article-title":"A computational approach to assessing the prognostic implications of BRAF and RAS mutations in patients with papillary thyroid carcinoma","author":"Haghzad","year":"2024","journal-title":"Endocrine"},{"key":"2024092306074217200_R6","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chemphyslip.2011.09.004","article-title":"Membrane-active host defense peptides\u2013challenges and perspectives for the development of novel anticancer drugs","volume":"164","author":"Riedl","year":"2011","journal-title":"Chem Phys Lipids"},{"key":"2024092306074217200_R7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122686","article-title":"Role of anti-cancer peptides as immunomodulatory agents: potential and design strategy","volume":"14","author":"Tripathi","year":"2022","journal-title":"Pharmaceutics"},{"key":"2024092306074217200_R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19763","article-title":"Engineering chimeric autoantibody receptor T cells for targeted B cell depletion in multiple sclerosis model: an in-vitro study","volume":"9","author":"Sahlolbei","year":"2023","journal-title":"Heliyon"},{"key":"2024092306074217200_R9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.intimp.2017.10.020","article-title":"Polyactin A is a novel and potent immunological adjuvant for peptide-based cancer vaccine","volume":"54","author":"Wang","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"2024092306074217200_R10","doi-asserted-by":"publisher","DOI":"10.1002\/pep2.24171","article-title":"Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates","volume":"112","author":"Worm","year":"2020","journal-title":"Pept Sci"},{"key":"2024092306074217200_R11","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-023-00630-x","article-title":"High prevalence of mucosa-associated extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD)","volume":"22","author":"Kharaghani","year":"2023","journal-title":"Ann Clinic Microbiol Antimicrob"},{"key":"2024092306074217200_R12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jconrel.2017.02.006","article-title":"Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides","volume":"250","author":"Dissanayake","year":"2017","journal-title":"J Control Release"},{"key":"2024092306074217200_R13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030225","article-title":"Cell penetrating peptides, novel vectors for gene therapy","volume":"12","author":"Taylor","year":"2020","journal-title":"Pharmaceutics"},{"key":"2024092306074217200_R14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612931","article-title":"Peptide-based agents for cancer treatment: current applications and future directions","volume":"24","author":"Nh\u00e0n","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2024092306074217200_R15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020448","article-title":"Apoptosis: a target for anticancer therapy","volume":"19","author":"Pfeffer","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2024092306074217200_R16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/cdd.2017.183","article-title":"Why do BCL-2 inhibitors work and where should we use them in the clinic?","volume":"25","author":"Montero","year":"2018","journal-title":"Cell Death Differ"},{"key":"2024092306074217200_R17","doi-asserted-by":"publisher","first-page":"14098","DOI":"10.1073\/pnas.222539699","article-title":"Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer","volume":"99","author":"Yamada","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024092306074217200_R18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"2024092306074217200_R19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/ijc.24027","article-title":"A novel peptide from human apolipoprotein (a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells","volume":"124","author":"Yi","year":"2009","journal-title":"Int J Cancer"},{"key":"2024092306074217200_R20","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114044","article-title":"Cell-penetrating peptides in protein mimicry and cancer therapeutics","volume":"180","author":"Zorko","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"2024092306074217200_R21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13060890","article-title":"Cell-penetrating peptides: applications in tumor diagnosis and therapeutics","volume":"13","author":"Stiltner","year":"2021","journal-title":"Pharmaceutics"},{"key":"2024092306074217200_R22","doi-asserted-by":"publisher","DOI":"10.1016\/j.medidd.2021.100092","article-title":"Cell-penetrating peptides as part of therapeutics used in cancer research","volume":"10","author":"Matijass","year":"2021","journal-title":"Med Drug Discovery"},{"key":"2024092306074217200_R23","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7184","article-title":"Metabolite signature of human malignant thyroid tissue: a systematic review and meta-analysis","volume":"13","author":"Razavi","year":"2024","journal-title":"Cancer Med"},{"key":"2024092306074217200_R24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/cbr.2014.1741","article-title":"Peptide receptor radionuclide therapy: an overview","volume":"30","author":"Dash","year":"2015","journal-title":"Cancer Biother Radiopharm"},{"key":"2024092306074217200_R25","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200004","article-title":"Anti-cancer peptides: classification, mechanism of action, reconstruction and modification","volume":"10","author":"Xie","year":"2020","journal-title":"Open Biology"},{"key":"2024092306074217200_R26","article-title":"Parallelizing assignment problem with DNA strands","volume":"18","author":"Khorsand","year":"2020","journal-title":"Iran J Biotechnol"},{"key":"2024092306074217200_R27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9749363","article-title":"Development of peptide-based vaccines for cancer","volume":"2022","author":"Abd-Aziz","year":"2022","journal-title":"J Oncol"},{"key":"2024092306074217200_R28","doi-asserted-by":"publisher","DOI":"10.3390\/ph12030114","article-title":"Lutathera\u00ae: the first FDA-and EMA-approved radiopharmaceutical for peptide receptor radionuclide therapy","volume":"12","author":"Hennrich","year":"2019","journal-title":"Pharmaceuticals"},{"key":"2024092306074217200_R29","article-title":"Padcev (Enfortumab Vedotin-ejfv) FDA Approved for the Treatment of Metastatic Urothelial Carcinoma","author":"Raedler"},{"key":"2024092306074217200_R30","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s40265-019-01175-0","article-title":"Polatuzumab vedotin: first global approval","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"2024092306074217200_R31","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baab055","article-title":"Peptipedia: a user-friendly web application and a comprehensive database for peptide research supported by machine learning approach","volume":"2021","author":"Quiroz","year":"2021","journal-title":"Database"},{"key":"2024092306074217200_R32","doi-asserted-by":"publisher","first-page":"D837","DOI":"10.1093\/nar\/gku892","article-title":"CancerPPD: a database of anticancer peptides and proteins","volume":"43","author":"Tyagi","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2024092306074217200_R33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25530-6","article-title":"ApInAPDB: a database of apoptosis-inducing anticancer peptides","volume":"12","author":"Faraji","year":"2022","journal-title":"Sci Rep"},{"key":"2024092306074217200_R34","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baaa004","article-title":"dbPepNeo: a manually curated database for human tumor neoantigen peptides","volume":"2020","author":"Tan","year":"2020","journal-title":"Database"},{"key":"2024092306074217200_R35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.04.025","article-title":"ACP-DL: a deep learning long short-term memory model to predict anticancer peptides using high-efficiency feature representation","volume":"17","author":"Yi","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"2024092306074217200_R36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7815","article-title":"iACP: a sequence-based tool for identifying anticancer peptides","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"key":"2024092306074217200_R37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jtbi.2013.08.037","article-title":"Predicting anticancer peptides with Chou\u2032s pseudo amino acid composition and investigating their mutagenicity via Ames test","volume":"341","author":"Hajisharifi","year":"2014","journal-title":"J Theor Biol"},{"key":"2024092306074217200_R38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/rr25","article-title":"Epithelial antimicrobial peptides in host defense against infection","volume":"1","author":"Bals","year":"2000","journal-title":"Respir Res"},{"key":"2024092306074217200_R39","doi-asserted-by":"crossref","DOI":"10.1145\/2945292.2945324","article-title":"Web-based molecular graphics for large complexes","author":"Rose","year":"2016"},{"key":"2024092306074217200_R40","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2024092306074217200_R41","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2024092306074217200_R42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/bmb.21213","article-title":"OligoCOOL: a mobile application for nucleotide sequence analysis","volume":"47","author":"Khorsand","year":"2019","journal-title":"Biochem Mol Biol Educ"},{"key":"2024092306074217200_R43","doi-asserted-by":"publisher","first-page":"D202","DOI":"10.1093\/nar\/gkm998","article-title":"AAindex: amino acid index database, progress report 2008","volume":"36","author":"Kawashima","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"2024092306074217200_R44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/protein\/9.1.27","article-title":"Analysis of amino acid indices and mutation matrices for sequence comparison and structure prediction of proteins","volume":"9","author":"Tomii","year":"1996","journal-title":"Protein Eng Des Sel"},{"key":"2024092306074217200_R45","doi-asserted-by":"publisher","first-page":"W414","DOI":"10.1093\/nar\/gkh350","article-title":"ESLpred: SVM-based method for subcellular localization of eukaryotic proteins using dipeptide composition and PSI-BLAST","volume":"32","author":"Bhasin","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"2024092306074217200_R46","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1073\/pnas.0607879104","article-title":"Predicting protein\u2013protein interactions based only on sequences information","volume":"104","author":"Shen","year":"2007","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Database"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baae092\/59235197\/baae092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/database\/article-pdf\/doi\/10.1093\/database\/baae092\/59235197\/baae092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T06:08:19Z","timestamp":1727071699000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/database\/article\/doi\/10.1093\/database\/baae092\/7762367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1093\/database\/baae092","relation":{},"ISSN":["1758-0463"],"issn-type":[{"value":"1758-0463","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"baae092"}}